Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1

Jeroen P. Jansen, Rachael Fleurence, Beth Devine, +7

Value in Health

NursingFamily MedicineCounselingNetwork Meta-analysisPart 1 +8

Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2

David C. Hoaglin, Neil Hawkins, Jeroen P. Jansen, +8

Value in Health

Family MedicineMeta-analysisPsychiatryNetwork-meta-analysis StudiesIntervention Science +6

A Genotype-Guided Strategy for Oral P2Y ₁₂ Inhibitors in Primary PCI

Daniel M.F. Claassens, Gerrit J.A. Vos, Thomas O. Bergmeijer, +17

New England Journal of Medicine

Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT)

Jarir At Thobari, Folkert W. Asselbergs, Cornelis Boersma, +7

Clinical Therapeutics

Pharmacoeconomic AnalysisHemodialysisUrologyRenal FunctionHealth Economics +10

Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: Cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands

Cornelis Boersma, Ron T. Gansevoort, Petros Pechlivanoglou, +5

Clinical Therapeutics

Cohort DataRenal CareUrologyRenal DiseasePreventive Medicine +9

Quantification of the Potential Impact of Cost-effectiveness Thresholds on Dutch Drug Expenditures Using Retrospective Analysis

Cornelis Boersma, Adriaan Broere, Maarten J. Postma

Value in Health

Cost-effectiveness ThresholdsPotential ImpactSubstance AbuseHealth PolicyHealth Economics +11

Exploratory Analysis of the Economically Justifiable Price of a Hypothetical RSV Vaccine for Older Adults in the Netherlands and the United Kingdom

Florian Zeevat, Jos Luttjeboer, Jeroen Paulissen, +4

The Journal of Infectious Diseases

On Discounting of Health Gains from Human Papillomavirus Vaccination: Effects of Different Approaches

Tjalke A. Westra, M. Parouty, Werner Brouwer, +7

Value in Health

VaccinationDifferent ApproachesPreventive MedicineCervical CancerHealth Economics +9

Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in The Netherlands

Rimma Velikanova, Simon van der Schans, Matthias Bischof, +3

Value in Health

Early DiagnosisPrimary CareNeonatologyNewborn ScreeningHealth Policy +11

Compliance, persistence, and switching patterns for ACE inhibitors and ARBs.

Stefan Vegter, Ho Nhu Nguyen, Sipke T. Visser, +3

PubMed